CIDARA THERAPEUTICS, INC. Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
CIDARA THERAPEUTICS, INC. reported Undistributed Earnings (Loss) Allocated to Participating Securities, Basic of $0 for the 3-month period ending 2023-09-30, per its 10-K filed 2024-04-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic · last filed 2024-04-22
- CIDARA THERAPEUTICS, INC. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2023-03-31 was $636.00K.
- CIDARA THERAPEUTICS, INC. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2022-09-30 was $2.93M.
- CIDARA THERAPEUTICS, INC. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2022-03-31 was $0.00.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 3 month |
|---|---|
| 2023-09-30 | $0.00 10-K · filed 2024-04-22 |
| 2023-03-31 | $636.00K 10-K · filed 2024-04-22 |
| 2022-09-30 | $2.93M 10-K · filed 2024-04-22 |
| 2022-03-31 | $0.00 10-K · filed 2024-04-22 |